The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Inquirer on MSN2h
US approves first-ever obstructive sleep apnea drugOn December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in the journal ...
At 40, LeBron says he could play at high level 5 to 7 more years --... Updated 4 minutes ago LeBron James, who celebrated his 40th birthday Monday, says he could play at a high level for "another ...
New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback